INVESTOR PRESENTATIONS • March 27, 2020
Sanofi hosted a conference call on its collaboration with Translate Bio to develop a novel mRNA vaccine candidate against COVID-19, on March 27, 2020.
If you wish to continue to this external website, click Proceed.
It is provided for information only. Sanofi assumes no responsibility for the information presented on this website.